张 斌, 孟 然, 赵洪猛, 曹旭晨. 隐匿型乳腺癌的临床诊治要点[J]. 中国肿瘤临床, 2010, 37(8): 477-480. DOI: 10.3969/j.issn.1000-8179.2010.08.016
引用本文: 张 斌, 孟 然, 赵洪猛, 曹旭晨. 隐匿型乳腺癌的临床诊治要点[J]. 中国肿瘤临床, 2010, 37(8): 477-480. DOI: 10.3969/j.issn.1000-8179.2010.08.016
ZHANG Bin, MENG Ran, ZHAO Hongmeng, CAO Xuchen. Key Issues of Clinical Management for Occult Breast Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 37(8): 477-480. DOI: 10.3969/j.issn.1000-8179.2010.08.016
Citation: ZHANG Bin, MENG Ran, ZHAO Hongmeng, CAO Xuchen. Key Issues of Clinical Management for Occult Breast Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 37(8): 477-480. DOI: 10.3969/j.issn.1000-8179.2010.08.016

隐匿型乳腺癌的临床诊治要点

Key Issues of Clinical Management for Occult Breast Cancer

  • 摘要: 隐匿型乳腺癌(Occult breast cancer ,OBC )是以腋窝淋巴结转移癌为主要表现的一种少见的乳腺癌表现。对于这类患者应当进行完善的术前检查,不仅需要包括标准的双侧乳腺摄影片,还要通过超声和核磁共振评估双侧乳腺和腋窝淋巴结,以寻找原发病灶。由于此类患者具有较高的局部复发风险,因此不推荐单纯对乳腺进行观察,乳房局部治疗应包括全乳切除,也可以考虑保留乳房联合全乳放疗。同时也应进行腋窝淋巴结清扫以提高局部控制并且完善分期。此外,患者还可以接受新辅助或辅助全身治疗。虽然隐匿性乳腺癌伴腋窝转移患者的疾病分期为T0N1-2M0 期,但比同期别原发性乳腺癌预后更好,腋窝淋巴结转移数目,尤其是小于4 枚转移与4 枚或以上转移相比仍然是最为可靠的预测结局的因素。

     

    Abstract: Occult breast cancer is a rare type of breast cancer with metastasis in the axillary lymph nodes as the first sign. For these patients, a thorough preoperative clinical evaluation should be performed including standard radiographic imaging with bilateral mammography and ultrasound and magnetic resonance imaging of the breast. Simple observation of the breast is not recommended due to high rate of loco-regional recurrence. Treatment for occult breast cancer includes mastectomy or breast-conserving therapy combined with irradiation to the whole breast. Axillary lymph node dissection should be performed in order to obtain better local control and complete staging information. Further, patients can also be treated with systemic adjuvant chemotherapy. Although occult breast cancer is considered as T0N1/2M0 disease, the progno -sis appears to be more favorable than that in those with stage Ⅱbreast cancer. The number of positive lymph nodes re-mains the most reliable predictor for the prognosis of occult breast cancer.

     

/

返回文章
返回